Results 1 to 10 of about 9,307,341 (282)
Crohn's disease is an inflammatory bowel disease that is characterized by chronic inflammation of any part of the gastrointestinal tract, has a progressive and destructive course and is increasing in incidence worldwide. Several factors have been implicated in the cause of Crohn's disease, including a dysregulated immune system, an altered microbiota ...
G. Roda +8 more
semanticscholar +7 more sources
Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy?
Within the IBD entity of Crohn's disease, there is currently no differentiation between ileal and colonic manifestation for recruitment of patients in clinical trials, well-powered analysis of study results or therapeutic decisions in daily clinical ...
Raja Atreya +5 more
doaj +1 more source
Crohn's disease what we know about it, symptoms, diagnosis, treatment
Crohn's disease is a chronic disease. It most often begins between the ages of 15 and 35 and lasts a lifetime. The earliest radiographic findings are aphthous ulcers. It can cause mouth-to-anal lesions and extra-intestinal complications. Typical symptoms
Monika Sosna +2 more
doaj +1 more source
Knife cut fissures: A clue for vulval crohn's disease!!
Crohn's disease is an inflammatory bowel disorder with various extraintestinal manifestations. Vulva is rarely involved in Crohn's disease and occasionally may constitute the only sign of the disease.
M L Ranjitha +3 more
doaj +1 more source
Crohn's disease - diagnosis and treatment
AdmissionCrohn's disease belongs to the group of chronic and still incurable diseases. It has periods of exacerbation and partial or complete remission. It mainly affects young people.
Patrycja Ręba
doaj +1 more source
Crohn's disease or Crohn's diseases? [PDF]
Disease behaviour in Crohn’s disease is dynamic and not stable over time In their landmark paper of 1932, Crohn, Ginzburg, and Oppenheimer1 described “a disease of the terminal ileum, affecting mainly young adults and characterised by a subacute or chronic necrotising and cicratrising inflammation.
Arnott, IDR, Satsangi, J
openaire +4 more sources
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
BACKGROUND Upadacitinib, an oral selective Janus kinase (JAK) inhibitor, is under investigation for the treatment of Crohn's disease. METHODS In two phase 3 induction trials (U-EXCEL and U-EXCEED), we randomly assigned patients with moderate-to-severe ...
E. Loftus +18 more
semanticscholar +1 more source
The burden of inflammatory bowel disease (IBD) in Australia is increasing but national data about the current prevalence are limited. We aimed to estimate the prevalence of IBD (including Crohn's disease, ulcerative colitis and unspecified IBD) as well ...
Doreen Busingye +2 more
doaj +1 more source
Whereas typical Crohn’s disease is confined to the terminal ileum and presents with abdominal pain and diarrhea, gastroduodenal manifestations of Crohn’s disease are rare, with often asymptomatic patient presentations and inconclusive diagnostic testing.
Clive Jude Miranda +4 more
doaj +1 more source

